Maze Therapeutics, Inc. - Common Stock - par value $0.001 per share (MAZE)

CUSIP: 578784100

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock - par value $0.001 per share
Shares outstanding
48,247,400
Total 13F shares
48,370,362
Share change
+4,663,462
Total reported value
$2,003,833,352
Put/Call ratio
0%
Price per share
$41.43
Number of holders
143
Value change
+$199,439,391
Number of buys
98
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP 578784100?
CUSIP 578784100 identifies MAZE - Maze Therapeutics, Inc. - Common Stock - par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Maze Therapeutics, Inc. - Common Stock - par value $0.001 per share (MAZE) as of Q4 2025

As of 31 Dec 2025, Maze Therapeutics, Inc. - Common Stock - par value $0.001 per share (MAZE) was held by 143 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 48,370,362 shares. The largest 10 holders included Frazier Life Sciences Management, L.P., TRV GP IV, LLC, Deep Track Capital, LP, ARCH Venture Management, LLC, JANUS HENDERSON GROUP PLC, BlackRock, Inc., a16z Capital Management, L.L.C., VANGUARD GROUP INC, VR ADVISER, LLC, and Alphabet Inc.. This page lists 143 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.